Diabeteszentrum Bad Lauterberg

Recent papers from Diabeteszentrum Bad Lauterberg

1. Wild ungulates and salvage logging modulate disturbance effects on moth communities in spruce‐dominated forestsJournal of Applied Ecology · 2025
2. Large‐scale forest disturbance and associated management shape bird communities in Central European spruce forestsJournal of Applied Ecology · 2024
3. Evaluation of frailty in geriatric patients undergoing cardiac rehabilitation after cardiac procedure: results of a prospective, cross-sectional studyBMC Sports Science Medicine and Rehabilitation · 2024
4. The prevalence and impact of sarcopenia in older cardiac patients undergoing inpatient cardiac rehabilitation – results from a prospective, observational cohort pre-studyBMC Geriatrics · 2024
5. Prehabilitation in older patients prior to elective cardiac procedures (PRECOVERY): study protocol of a multicenter randomized controlled trialTrials · 2023
6. Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical PerspectiveDiabetes & Metabolism Journal · 2022
7. Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 DiabetesDiabetes Care · 2020
8. Prediction of Individual Basal Rate Profiles From Patient Characteristics in Type 1 Diabetes on Insulin Pump TherapyJournal of Diabetes Science and Technology · 2020
9. Patients with Type 1 Diabetes Treated with Insulin Pumps Need Widely Heterogeneous Basal Rate Profiles Ranging from Negligible to Pronounced Diurnal VariabilityJournal of Diabetes Science and Technology · 2020
10. A Prospective, Randomized Trial Testing Different Regimens of Carbohydrate Administration to Prevent Major Reduction in Plasma Glucose Follwing a Standardized Bout of Moderate Physical Activity in Patients with Type 1 DiabetesExperimental and Clinical Endocrinology & Diabetes · 2020
11. Twenty-Four Hour Fasting (Basal Rate) Tests to Achieve Custom-Tailored, Hour-by-Hour Basal Insulin Infusion Rates in Patients With Type 1 Diabetes Using Insulin Pumps (CSII)Journal of Diabetes Science and Technology · 2019
12. Clinical Predictors of the Need for Further Treatment Escalation in Patients with Type 2 Diabetes on Basal Insulin Therapy – A Retrospective Observational StudyExperimental and Clinical Endocrinology & Diabetes · 2019
13. Owning a Dog as a Determinant of Physical Activity and Metabolic Control in Patients With Type 1 and Type 2 Diabetes MellitusExperimental and Clinical Endocrinology & Diabetes · 2019
14. Importance of localization of insulinomas: a systematic analysisJournal of Hepato-Biliary-Pancreatic Sciences · 2019
15. Basal rate tests (24‐hour fasts) performed in type‐1 diabetic subjects with either absolute fasting or snacks containing negligible carbohydrate amounts result in similar glucose profiles: A randomized controlled prospective trialDiabetes Obesity and Metabolism · 2017
16. Addition of a dipeptidyl peptidase‐4 inhibitor, sitagliptin, to ongoing therapy with the glucagon‐like peptide‐1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetesDiabetes Obesity and Metabolism · 2016
17. Feedback suppression of meal‐induced glucagon‐like peptide‐1 ( GLP ‐1) secretion mediated through elevations in intact GLP ‐1 caused by dipeptidyl peptidase‐4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatmentDiabetes Obesity and Metabolism · 2016
18. Linagliptin and pioglitazone combination therapy versus monotherapy with linagliptin or pioglitazone: A randomised, double-blind, parallel-group, multinational clinical trialDiabetes and Vascular Disease Research · 2016
19. Fasting C-peptide and Related Parameters Characterizing Insulin Secretory Capacity for Correctly Classifying Diabetes Type and for Predicting Insulin Requirement in Patients with Type 2 DiabetesExperimental and Clinical Endocrinology & Diabetes · 2016
20. A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 DiabetesENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2015